SCR-LIP-000739 · Claim · machine-readable JSON →
DXA leg-fat indices are proposed as an auxiliary tool to suggest or exclude lipedema in borderline cases.
General proposition consolidated from 1 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- very low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (1)
- Lipedema: pathophysiological insights and therapeutic strategies — An update for dermatologists (2026) ✓ verified — consistent · review · 2026 · reading confidence: high
“DEXA index (Buso et al.): leg-fat/total-fat ratio ≥0.384 suggests lipedema; <0.383 useful for exclusion — auxiliary tool for borderline cases”
Review citing a DXA leg-fat/total-fat ratio of 0.384 or more as suggesting lipedema and below 0.383 as useful for exclusion in borderline cases.
The review explicitly cites a DEXA leg-fat/total-fat ratio cutoff suggesting lipedema fat distribution, directly addressing whether DXA can identify lipedema fat distribution, though it is a narrative synthesis citing secondary data.
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000029